Clinical Trial Update: Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating VX-828 in healthy participants and in people with cystic fibrosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• VX-828

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Cystic Fibrosis | Phase 1 | Status: RECRUITING